Jefferies Group’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History

Jefferies Group’s Portfolio BLCM Stock Details BLCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,184	Closed	-$54K	–	3149
2019 Q2	$54K	Sell	3,184 -1,079	-25%	-$29.2K	﹤0.01%	2362
2019 Q1	$144K	Sell	4,263 -5,151	-55%	-$172K	﹤0.01%	2030
2018 Q4	$275K	Buy	9,414 +4,734	+101%	+$210K	﹤0.01%	1687
2018 Q3	$288K	Buy	4,680 +2,533	+118%	+$171K	﹤0.01%	1897
2018 Q2	$158K	Buy	2,147 +914	+74%	+$71.2K	﹤0.01%	2072
2018 Q1	$81K	Buy	1,233 +161	+15%	+$12.2K	﹤0.01%	2094
2017 Q4	$90K	Buy	+1,072	New	+$105K	﹤0.01%	2336
2015 Q3	–	Sell	-1,500	Closed	-$319K	–	3228
2015 Q2	$319K	Buy	+1,500	New	+$368K	﹤0.01%	1759

Other funds holding BLCM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Jefferies Group's BLCM Position: Q3 2019 in Review

Jefferies Group sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q3 2019, closing a stake of 3,184 shares — an estimated $54K sold.

Jefferies Group first reported a position in BLCM in Q2 2015 and held it in 8 quarters. The position peaked at $319K in Q2 2015. 67 funds tracked by Wall St. Rank hold BLCM as of Q3 2019.

Jefferies Group reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
Jefferies Group sold 3,184 Bellicum Pharmaceuticals, Inc. shares in Q3 2019, an estimated $54K.
Jefferies Group first reported a position in Bellicum Pharmaceuticals, Inc. in Q2 2015 and held it in 8 quarters.
Jefferies Group's Bellicum Pharmaceuticals, Inc. position peaked at $319K in Q2 2015.
67 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q3 2019.

Based on Jefferies Group's 13F filing for Q3 2019, filed 13 Nov 2019.